AcneFeatured PodcastPodcast Highlights

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

By March 2, 2021April 1st, 2022No Comments

JDD Multimedia

Love17

JDD Podcast

Listen Now

Play Video

How to Listen

Oral Antibiotics for Acne: Basic Concepts & Practical Considerations

Drs. Mahmoud Ghannoum, Emmy Graber & Adam Friedman

 

Antibiotic use for inflammatory skin diseases is a staple in dermatology. Like milk is the answer to a chunky peanut butter sandwich (just go with me on this), so too have tetracycline antibiotics been married to the management of Acne Vulgaris. And just as that delicious combo comes at a fattening cost, the overuse and abuse of antibiotics has an impressive and significant impact both on the risk for antimicrobial resistance and gut/cutaneous dysbiosis.

To get to the piloseabeous unit of the matter, JDD Podcast host Dr. Adam Friedman picks the brains of AAA experts Dr. Emmy Graber and Dr. Mahmoud Ghannoum to provide a true bench to bedside review of the issues at hand. Pop in to learn how to interpret minimum inhibitory concentrations (MIC), understand newly identified information on dysbiosis (including impaired microbiota), and appreciate the implications of indiscriminate use of broad-spectrum antibiotics in acne therapy including the clinical consequence of antibiotic resistance and benefits of narrow-spectrum agents.

Listen Now
Learning Objectives
Upon completion of this podcast participants should be able to:
  • Describe the differences between antibiotic types and their use in acne therapy
  • Discuss interpretation and measurement of MIC, resistance and dysbiosis
  • Summarize the clinical implications of antibiotic resistance
  • Summarize the clinical implications of dysbiosis
This enduring activity is supported by an independent medical education grant provided by Almirall, LLC.
Disclosures
Adam Friedman, MD, FAAD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speakers’ Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
Mahmoud Ghannoum, PhD – Grant/Research: Almirall. Consultant: Almirall.
Emmy M. Graber, MD, MBA – Grant/Research: Ortho Dermatologics. Consultant: Almirall, Digital Diagnostics, Sebacia, SolGel. Speakers’ Bureau: Almirall

You May Also Like

From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Life's an itch sometimes….am I right? Pruritus can pick apart the fabric of one's life as both a symptom of a primary skin disease or even as a…
Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array of nonsteroidal options, understanding the underpinnings to both use them for their intended purpose, but even more fun, OOOOOOFFFFFF LLLLLLAAAAABBBBEEEELLLL (clearly a fan of off label), is paramount to patient outcomes. Be not overwhelmed I say, as the bench to bedside badass Dr. Christopher Bunick is here for all your on and off label needs. Take a break from the typical Tuesday with a topical translational deep dive into the tantalizing options as host Dr. Adam Friedman tees off with Dr. Bunick for what is certain to be a “tough” (as the kids say) podcast.

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow your roll you say? The paradigm shift has occurred and for many of our established patients it’s now about cleaning up the biologic leftovers, especially when located on far reaching and sensitive sites. How to do so? So glad you asked, as we are so fortunate Dr. Peter Lio, clinical assistant professor of dermatology and pediatrics at Northwestern, joined host Dr. Adam Friedman to provide his experiences to pick apart the NYC diner menu of topical option add-ons to our powerful buffet of advanced systemics. Make sure to come hungry!

Pspecial Psite Psoriasis Pearls: Picking the Right Combo Meal for your Patients

| Featured Articles, Featured Podcast, Podcast Highlights, Psoriasis, The Latest | No Comments
Featured Podcast What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow…

Tags:

Leave a Reply

Close Menu